Join us this evening March 19, 2019 at 7:00 pm CST!

5:00pm PST..6:00pm MST..7:00pm CST..8:00pm EST

→Listen Live →HERE

Call in # 917-388-4520

Press 1 to speak to the host

Hosted by Arlene Mullin

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

What is the consequence of the kidney shortage?

It is a catastrophe.  We conservatively estimate that each year 43,000 patients suffer on dialysis and die prematurely because of the shortage.  That’s equivalent to 85 fully loaded 747s crashing each year.  That’s 118 patients dying each day.  Since 1988 (when data collection began) almost 1 million patients have suffered and died prematurely because of the shortage.

Our guest: David W. Moskowitz, MD

  • – Chairman, Chief Executive Officer, and Chief Medical Officer, and Founder of GenoMed, Inc. (GenoMed.com) Dr. Moskowitz majored in Chemistry (summa cum laude) at Harvard College, Biochemistry (first class honours) at Merton College, Oxford, and received an MD (cum laude) from the Harvard-MIT Division in Health Sciences and Technology (Harvard Medical School). He trained for 7 years in Internal Medicine, Biochemistry, and Nephrology at Washington University School of Medicine in St. Louis before spending 11 years on the faculty of St. Louis University School of Medicine. Since 1994, Dr. Moskowitz has experienced first hand the clinical effectiveness of knowing a disease-associated gene (the angiotensin converting enzyme, or ACE, gene). Dr. Moskowitz is a pioneer in the field of medical genomics, and has been recognized for his groundbreaking treatment of diseases associated with the angiotensin I-converting enzyme, such as chronic renal failure due to hypertension or type II diabetes.

All patient cases have been documented and verified for accuracy.

Arlene Mullin — advocate, 20 years experience guiding patients and their families through all aspects of End Stage Renal Disease treatments.  Mullin has served patients in a majority of states, engaging both Medicare and state health authorities towards resolution of quality care issues at clinics.  Comprehensive knowledge of care issues on clinic level.  She was instrumental in getting the hearings on aging before the U.S. Senate in 2000 where she testified on patient care issue within the dialysis industry.

https://dialysisadvocates.com/committed-advocacy/

Dialysis Advocates is grateful for the opportunity to get this important message out for all Dialysis Patients.

We will be having a guest on the first part of every show. Then we will open the Microphones for the Town Hall. Patients and others will be able to discuss concerns and solutions. It will be a patient group, including families.

Advertisements